Hilgers R D, Standefer J C, Bowling M C, Greeley P
Department of Obstetrics and Gynecology, University of New Mexico Medical Center, Albuquerque.
Int J Gynaecol Obstet. 1988 Dec;27(3):421-5. doi: 10.1016/0020-7292(88)90124-5.
A recent report of serum methotrexate (MTX) levels measured during treatment of gestational trophoblastic neoplasia (GTN) led us to determine MTX and human chorionic gonadotropin (beta-hCG) levels in a patient with low-risk metastatic GTN with a pulmonary metastasis. Peak MTX concentrations exceeded 10(-6) mol/l considered by many investigators to be within the therapeutic range against many human tumors. Serum beta-hCG levels did not decline during MTX administration; however, after 5 days of MTX a steep dose-response curve was observed which continued during 5 courses of chemotherapy.
最近一份关于妊娠滋养细胞肿瘤(GTN)治疗期间血清甲氨蝶呤(MTX)水平的报告促使我们测定了一名患有低风险转移性GTN且伴有肺转移患者的MTX和人绒毛膜促性腺激素(β-hCG)水平。MTX峰值浓度超过了许多研究者认为对多种人类肿瘤具有治疗作用的10^(-6) mol/L。在给予MTX期间血清β-hCG水平并未下降;然而,在MTX治疗5天后观察到一条陡峭的剂量反应曲线,该曲线在5个化疗疗程中持续存在。